Novo Nordisk A/S (ADR)  

(Public, NYSE:NVO)   Watch this stock  
Find more results for NVO
+0.50 (0.92%)
Nov 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 54.57 - 54.82
52 week 41.72 - 60.34
Open 54.65
Vol / Avg. 426,105.00/1.68M
Mkt cap 113.17B
P/E 30.15
Div/yield 0.76/1.39
EPS 1.82
Shares 2.06B
Beta 0.91
Inst. own 10%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 31.29% 29.82%
Operating margin 44.71% 38.84%
EBITD margin - 42.71%
Return on average assets 40.39% 35.93%
Return on average equity 81.79% 63.92%
Employees 40,261 -
CDP Score - 97 B


Novo Alle
+45-44-448888 (Phone)
+45-44-436633 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Novo Nordisk A/S is a healthcare company. The Company is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. It has a range of diabetes product portfolio, including a portfolio of modern insulins as well as a human once-daily GLP-1 analog. It operates in two segments: diabetes care and biopharmaceuticals. The Company's diabetes care segment covers insulins, GLP-1, other protein-related products (such as glucagon, protein-related delivery systems and needles), oral anti-diabetic drugs and obesity. Its biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy and hormone replacement therapy. The primary production facilities owned by the Company are located at a number of sites in Denmark, and internationally in the United States, France, China and Brazil.

Officers and directors

Goran A. Ando M.D. Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Kaare Schultz President, Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Lars Rebien Soerensen Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Jeppe Christiansen Vice Chairman of the Board
Age: 55
Bio & Compensation  - Reuters
Jesper Brandgaard Chief Financial Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Lars Fruergaard Joergensen Executive Vice President of Corporate Development and Chief of Staff
Age: 48
Bio & Compensation  - Reuters
Mads Krogsgaard Thomsen Chief Science Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Jakob Riis Executive Vice President of Marketing, Medical Affairs and Stakeholder Engagement
Age: 48
Bio & Compensation  - Reuters
Sylvie L. Gregoire Ph.D. Director
Age: 54
Bio & Compensation  - Reuters
Liselotte Hyveled Director, Employee Representative
Age: 49
Bio & Compensation  - Reuters